Wim Van Hecke, PhD, is the founder and CEO of icometrix, a leading technology company that is focused on improving the lives of people with neurological conditions. The FDA-cleared and CE-marked icobrain AI solution quantifies clinically meaningful information from brain MRI and CT scans. Specifically for Alzheimer's disease and dementia, icobrain evaluates volumes of the hippocampus, different brain lobes, and so on in individuals and compares these with a large healthy population. A specific solution for ARIA monitoring has been developed in collaboration with the pharmaceutical industry and is FDA-pending. Dr. Van Hecke is an academic engineer by training with two master's degrees in applied biomedical engineering and neuroimaging, and a PhD in medicine. He is the author of more than 250 scientific publications and the editor of a clinical neuroimaging handbook. He is also a visiting professor at the University of Brussels.
